Drug-resistant salmonella tied to moringa capsules

CHICAGO, Feb. 24, 2026 — Federal health officials are warning consumers not to use certain Rosabella brand moringa powder capsules after investigators linked them to an outbreak of extensively drug-resistant Salmonella, with seven illnesses and three hospitalizations across seven states, according to the CDC outbreak notice.

The agency said the strain resists common first-line antibiotics, meaning treatment choices may be limited if infections become severe, the CDC media release noted.

Recall and distribution

The FDA’s outbreak investigation says the recalled capsules were sold nationwide and internationally, largely online, and the agency is conducting traceback and sampling to pinpoint the contamination source.

In a separate recall notice, Ambrosia Brands said lots with 2027 expiration dates in white bottles with green labels are affected and urged customers to dispose of the product.

State alerts and symptoms

Illinois health officials reported one case in the state and echoed CDC advice to stop using the capsules, wash surfaces and seek care for severe symptoms, according to the Illinois Department of Public Health advisory.

Symptoms typically include diarrhea, fever and abdominal cramps within a few days of exposure, and severe cases can affect young children, older adults and people with weakened immune systems, the FDA investigation page says.

Why resistance matters

The CDC outbreak notice says the strain is resistant to commonly recommended antibiotics and may require susceptibility testing to guide treatment decisions.

FDA investigators said they are still determining the contamination source and warned that additional products could be involved as the probe continues, according to the FDA update.

Consumers who purchased Rosabella moringa capsules should check lot codes, discard recalled products and contact a health provider if they develop severe symptoms, per the CDC guidance.

How we report: We select the day’s most important stories, confirm facts across multiple reputable sources, and avoid anonymous sourcing. Our goal is clear, balanced coverage you can trust—because transparency and verification matter for informed readers.